BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Down 94.6% in June

BioSyent Inc. (OTCMKTS:BIOYF) was the recipient of a significant decrease in short interest in June. As of June 15th, there was short interest totalling 200 shares, a decrease of 94.6% from the May 31st total of 3,700 shares. Based on an average daily volume of 2,100 shares, the short-interest ratio is presently 0.1 days.

BioSyent Price Performance

Shares of OTCMKTS BIOYF opened at $7.49 on Friday. The firm has a fifty day moving average price of $6.67 and a 200-day moving average price of $6.52. BioSyent has a 1 year low of $5.49 and a 1 year high of $7.76.

BioSyent Cuts Dividend

The company also recently disclosed a dividend, which was paid on Saturday, June 15th. Stockholders of record on Monday, June 3rd were paid a $0.0331 dividend. The ex-dividend date of this dividend was Friday, May 31st. This represents a dividend yield of 2.02%.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.